Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium ...

How to Inject Semaglutide This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ...

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.

Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer vaccine, when combined with ...